Meeting
2018 Gastrointestinal Cancers Symposium
Circulating angiogenesis-related markers as predictors of benefit from regorafenib in metastatic colorectal cancer (mCRC) patients (pts).
Authors
Carlotta Antoniotti
Azienda Ospedaliera-Universitaria Pisana, Pisa, Italy
Carlotta Antoniotti , Federica Marmorino , Marzia Pennati , Nadia Zaffaroni , Daniele Rossini , Beatrice Borelli , Gemma Zucchelli , Roberto Moretto , Filippo Pietrantonio , Gianluca Masi , Francesca Vannini , Camilla Colombo , Serenella Gini , Alessandra Saettini , Laura Delliponti , Isa Maura Brunetti , Elisabetta Pfanner , Alfredo Falcone , Chiara Cremolini
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Translational Research
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 675)
DOI
10.1200/JCO.2018.36.4_suppl.675
Abstract #
675
Poster Bd #
F12
Abstract Disclosures
Similar Posters
Poster
2016 Gastrointestinal Cancers Symposium
Analysis of plasma protein biomarkers from the phase 3 CONCUR study of regorafenib in Asian patients with metastatic colorectal cancer (mCRC).
First Author: Michael Teufel
Poster
2014 Gastrointestinal Cancers Symposium
Assessment of IL-6, IL-8, bFGF, PDGF-BB, and VEGF-A as prognostic and predictive biomarkers for anti-VEGF in metastatic colorectal cancer (mCRC).
First Author: Timothy Jay Price
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Plasma biomarkers to predict clinical outcomes of FOLFIRI plus ramucirumab (RAM) as second-line treatment for RAS wild-type metastatic colorectal cancer: JACCRO CC-16AR.
First Author: Yu Sunakawa
Poster
2022 ASCO Annual Meeting
Analysis of plasma angiogenesis factors on the efficacy of first-line (1L) chemotherapy (chemo) combined with biologics in RAS wild-type metastatic colorectal cancer (mCRC): Results from GI-SCREEN CRC Ukit study.
First Author: Satoshi Yuki